Roche Holding (RHHBY)
(Delayed Data from OTC)
$38.85 USD
-0.58 (-1.47%)
Updated Nov 5, 2024 12:12 PM ET
3-Hold of 5 3
B Value C Growth D Momentum C VGM
Price, Consensus and EPS Surprise
RHHBY 38.85 -0.58(-1.47%)
Will RHHBY be a Portfolio Killer in November?
Zacks Investment Research is releasing its prediction for RHHBY based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for RHHBY
HALO Beats Q3 Earnings & Sales Estimates, Raises '24 View, Stock Up
Alnylam Q3 Loss In Line With Estimates, Revenues Miss, Stock Down
RHHBY: What are Zacks experts saying now?
Zacks Private Portfolio Services
Biogen Beats on Q3 Earnings & Sales, Raises '24 EPS View
AbbVie Trumps Q3 Earnings & Sales Estimates, Raises '24 EPS View
Pharma Stock Roundup: RHHBY Earnings, Drug Pipeline & Regulatory News
Other News for RHHBY
Genentech to present blood disorders data at ASH
Genentech to present blood disorders data at ASH
Roche downgraded to Hold from Buy at Erste Group
Erste Group gets more bearish on Roche, downgrades shares
Barclays Reaffirms Their Hold Rating on Roche Holding AG (RHHVF)